biosimilar products Archives

Global Sales of Samsung Bioepis’ 5 Biosimilars Jump 11 pct in 2021

SEOUL, Feb. 18 (Korea Bizwire) — Samsung Bioepis Co., a South Korean biopharmaceutical company, said Friday that global sales of its five biosimilar products, outside of the South Korean market, jumped 11 percent on-year in 2021. The combined sales of the five biosimilars — Infliximab, Etanercept, Adalimumab, Trastuzumab and Bevacizumab — came to around US$1.25 [...]

Global Sales of Samsung Bioepis’ Biosimilars Up 30 pct in H1

SEOUL, Aug. 13 (Korea Bizwire) — South Korean drugmaker Samsung Bioepis Co. said Friday that global sales of its five biosimilar products jumped 30 percent on-year during the first half of the year. Combined sales of the five biosimilars — Infliximab, Etanercept, Adalimumab, Trastuzumab, Bevacizumab — came to US$166 million in the January-June period, compared [...]